An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...
A biology-guided artificial intelligence model applied to routine pathology slides accurately predicted outcomes and response to immunotherapy in patients with metastatic non-small cell lung ...
An artificial intelligence (AI) model developed by researchers at The University of Texas MD Anderson Cancer Center ...
A machine learning model that analyzes patient demographics, electronic health record data, and routine blood test results predicted a patient's risk of hepatocellular carcinoma (HCC), the most common ...
Artificial intelligence is rapidly changing the job market, automating jobs across industries. Therefore, in such a scenario, upskilling oneself in industry-relevant AI skills becomes even more ...
Drug resistance remains a central barrier to durable responses across cancer therapies, spanning targeted agents, cytotoxic chemotherapy, endocrine ...
A model integrating deep learning with clinical and epidemiologic data may significantly improve lung cancer risk prediction based on LDCT screening.
Cost-Effectiveness of Maintaining Higher Stem-Cell Collection Thresholds in the Chimeric Antigen Receptor T-Cell Era for Multiple Myeloma Predicting severe adverse events (SAEs) in oncology is ...
Breast cancer is one of the most common malignancies worldwide, and mutations in the PI3K/AKT/mTOR (PAM) signaling pathway ...
A research team led by The Hong Kong University of Science and Technology (HKUST) has developed a pioneering artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results